|
|
Volumn 466, Issue 7309, 2010, Pages 916-918
|
|
Biotechnology: Crossing the barrier
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGT 190;
GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;
INSULIN RECEPTOR;
NEURTURIN;
UNCLASSIFIED DRUG;
AGT-190;
PROTEIN;
BIOTECHNOLOGY;
BLOOD BRAIN BARRIER;
BRAIN DISEASE;
BRAIN SURGERY;
CATHETER;
CEREBROSPINAL FLUID;
CLINICAL TRIAL;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
ENDOTHELIUM CELL;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE COST;
HUMAN;
HUNTINGTON CHOREA;
MOTOR PERFORMANCE;
NATIONAL HEALTH ORGANIZATION;
NERVE CELL NECROSIS;
NOTE;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PUTAMEN;
QUALITY OF LIFE;
VIRAL GENE DELIVERY SYSTEM;
ANIMAL;
BRAIN DISEASES;
CLINICAL TRIAL (TOPIC);
GENETICS;
INDWELLING CATHETER;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
METABOLISM;
ANIMALS;
BLOOD-BRAIN BARRIER;
BRAIN DISEASES;
CATHETERS, INDWELLING;
CLINICAL TRIALS AS TOPIC;
GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR;
HUMANS;
INJECTIONS, INTRAVENTRICULAR;
NEURTURIN;
PARKINSON DISEASE;
PROTEINS;
|
|
EID: 77955855339
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/466916a Document Type: Note |
|
Times cited : (18)
|
|
References (5)
|
